HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2

The aim of this study was to examine the association between HbA(1c) variability and the development of microalbuminuria as defined by an albumin/creatinine ratio ≥ 3.4 mg/mmol (≥ 30 mg/g) in at least two of three consecutive urine samples in Japanese patients with type 2 diabetes. HbA(1c) level was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 2012-08, Vol.55 (8), p.2128-2131
Hauptverfasser: Sugawara, A, Kawai, K, Motohashi, S, Saito, K, Kodama, S, Yachi, Y, Hirasawa, R, Shimano, H, Yamazaki, K, Sone, H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2131
container_issue 8
container_start_page 2128
container_title Diabetologia
container_volume 55
creator Sugawara, A
Kawai, K
Motohashi, S
Saito, K
Kodama, S
Yachi, Y
Hirasawa, R
Shimano, H
Yamazaki, K
Sone, H
description The aim of this study was to examine the association between HbA(1c) variability and the development of microalbuminuria as defined by an albumin/creatinine ratio ≥ 3.4 mg/mmol (≥ 30 mg/g) in at least two of three consecutive urine samples in Japanese patients with type 2 diabetes. HbA(1c) level was measured in 812 serially registered normoalbuminuric adults aged 21-79 years with type 2 diabetes. After registration, a 1-year period to establish baseline values for mean HbA(1c) and HbA(1c) variability (measured as the intrapersonal SD of serially collected HbA(1c)) was decided upon. The association between HbA(1c) variability and the development of microalbuminuria was determined by Cox regression analysis after adjustment for other risk factors for microalbuminuria. Microalbuminuria occurred in 193 patients during the observation period of (mean ± SD) 4.3 ± 2.7 years. Even after adjustment for mean HbA(1c), HbA(1c) variability was a significant predictor of microalbuminuria independently of the mean HbA(1c); the HR for every 1% (95% CI) increase in mean HbA(1c) was 1.22 (1.06, 1.40) (p = 0.005), and that for HbA(1c) variability was 1.35 (1.05, 1.72) (p = 0.019). The effects of these two variables were quite similar when 1 SD was used; the HR for every 1 SD increase (95% CI) in HbA(1c) was 1.23 (1.07, 1.43) (p = 0.005), and that for HbA(1c) variability was 1.20 (1.03, 1.39) (p = 0.019). HbA(1c) variability affects the development of microalbuminuria independently of mean HbA(1c) in type 2 diabetes. Further studies should be performed to evaluate the influence of HbA(1c) variability on other complications and in individuals of other ethnicities with type 2 diabetes.
doi_str_mv 10.1007/s00125-012-2572-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1024100188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1024100188</sourcerecordid><originalsourceid>FETCH-LOGICAL-p561-db60c799f210ac057c2794813df1ee7435cdcf071b8b7a953ed73a677b0e98be3</originalsourceid><addsrcrecordid>eNo1kE1Lw0AYhBdBbK3-AC-yx3qIvrubzSbeSv2oWBCk97Afb3Q1X80mlfx7A9bLDAzPzGEIuWJwywDUXQBgXEaTRFwqHqkTMmex4BHEPJ2R8xC-AEDIODkjM85lClnG5mS_Maslszf0oDuvjS99P1JdO9p_InV4wLJpK6x72hS08rZrdGmGytfDRFNf035skXLqpi72GO7pLgzfg9H0Vf9oTx-OOX3HDx_6bqT8gpwWugx4efQF2T097tabaPv2_LJebaNWJixyJgGrsqzgDLQFqSxXWZwy4QqGqGIhrbMFKGZSo3QmBToldKKUAcxSg2JBln-zbdfsBwx9XvlgsSx1jc0QcgY8no5jaTqh10d0MBW6vO18pbsx_39J_ALUAmeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024100188</pqid></control><display><type>article</type><title>HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Sugawara, A ; Kawai, K ; Motohashi, S ; Saito, K ; Kodama, S ; Yachi, Y ; Hirasawa, R ; Shimano, H ; Yamazaki, K ; Sone, H</creator><creatorcontrib>Sugawara, A ; Kawai, K ; Motohashi, S ; Saito, K ; Kodama, S ; Yachi, Y ; Hirasawa, R ; Shimano, H ; Yamazaki, K ; Sone, H</creatorcontrib><description>The aim of this study was to examine the association between HbA(1c) variability and the development of microalbuminuria as defined by an albumin/creatinine ratio ≥ 3.4 mg/mmol (≥ 30 mg/g) in at least two of three consecutive urine samples in Japanese patients with type 2 diabetes. HbA(1c) level was measured in 812 serially registered normoalbuminuric adults aged 21-79 years with type 2 diabetes. After registration, a 1-year period to establish baseline values for mean HbA(1c) and HbA(1c) variability (measured as the intrapersonal SD of serially collected HbA(1c)) was decided upon. The association between HbA(1c) variability and the development of microalbuminuria was determined by Cox regression analysis after adjustment for other risk factors for microalbuminuria. Microalbuminuria occurred in 193 patients during the observation period of (mean ± SD) 4.3 ± 2.7 years. Even after adjustment for mean HbA(1c), HbA(1c) variability was a significant predictor of microalbuminuria independently of the mean HbA(1c); the HR for every 1% (95% CI) increase in mean HbA(1c) was 1.22 (1.06, 1.40) (p = 0.005), and that for HbA(1c) variability was 1.35 (1.05, 1.72) (p = 0.019). The effects of these two variables were quite similar when 1 SD was used; the HR for every 1 SD increase (95% CI) in HbA(1c) was 1.23 (1.07, 1.43) (p = 0.005), and that for HbA(1c) variability was 1.20 (1.03, 1.39) (p = 0.019). HbA(1c) variability affects the development of microalbuminuria independently of mean HbA(1c) in type 2 diabetes. Further studies should be performed to evaluate the influence of HbA(1c) variability on other complications and in individuals of other ethnicities with type 2 diabetes.</description><identifier>EISSN: 1432-0428</identifier><identifier>DOI: 10.1007/s00125-012-2572-7</identifier><identifier>PMID: 22580991</identifier><language>eng</language><publisher>Germany</publisher><subject>Albuminuria - urine ; Asian Continental Ancestry Group ; Blood Glucose - metabolism ; Creatinine - urine ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - ethnology ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetic Angiopathies - blood ; Diabetic Angiopathies - ethnology ; Diabetic Angiopathies - physiopathology ; Diabetic Nephropathies - blood ; Diabetic Nephropathies - ethnology ; Diabetic Nephropathies - physiopathology ; Female ; Glycated Hemoglobin A - metabolism ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Proportional Hazards Models ; Registries ; Risk Factors ; Serum Albumin - metabolism</subject><ispartof>Diabetologia, 2012-08, Vol.55 (8), p.2128-2131</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22580991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sugawara, A</creatorcontrib><creatorcontrib>Kawai, K</creatorcontrib><creatorcontrib>Motohashi, S</creatorcontrib><creatorcontrib>Saito, K</creatorcontrib><creatorcontrib>Kodama, S</creatorcontrib><creatorcontrib>Yachi, Y</creatorcontrib><creatorcontrib>Hirasawa, R</creatorcontrib><creatorcontrib>Shimano, H</creatorcontrib><creatorcontrib>Yamazaki, K</creatorcontrib><creatorcontrib>Sone, H</creatorcontrib><title>HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2</title><title>Diabetologia</title><addtitle>Diabetologia</addtitle><description>The aim of this study was to examine the association between HbA(1c) variability and the development of microalbuminuria as defined by an albumin/creatinine ratio ≥ 3.4 mg/mmol (≥ 30 mg/g) in at least two of three consecutive urine samples in Japanese patients with type 2 diabetes. HbA(1c) level was measured in 812 serially registered normoalbuminuric adults aged 21-79 years with type 2 diabetes. After registration, a 1-year period to establish baseline values for mean HbA(1c) and HbA(1c) variability (measured as the intrapersonal SD of serially collected HbA(1c)) was decided upon. The association between HbA(1c) variability and the development of microalbuminuria was determined by Cox regression analysis after adjustment for other risk factors for microalbuminuria. Microalbuminuria occurred in 193 patients during the observation period of (mean ± SD) 4.3 ± 2.7 years. Even after adjustment for mean HbA(1c), HbA(1c) variability was a significant predictor of microalbuminuria independently of the mean HbA(1c); the HR for every 1% (95% CI) increase in mean HbA(1c) was 1.22 (1.06, 1.40) (p = 0.005), and that for HbA(1c) variability was 1.35 (1.05, 1.72) (p = 0.019). The effects of these two variables were quite similar when 1 SD was used; the HR for every 1 SD increase (95% CI) in HbA(1c) was 1.23 (1.07, 1.43) (p = 0.005), and that for HbA(1c) variability was 1.20 (1.03, 1.39) (p = 0.019). HbA(1c) variability affects the development of microalbuminuria independently of mean HbA(1c) in type 2 diabetes. Further studies should be performed to evaluate the influence of HbA(1c) variability on other complications and in individuals of other ethnicities with type 2 diabetes.</description><subject>Albuminuria - urine</subject><subject>Asian Continental Ancestry Group</subject><subject>Blood Glucose - metabolism</subject><subject>Creatinine - urine</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - ethnology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetic Angiopathies - blood</subject><subject>Diabetic Angiopathies - ethnology</subject><subject>Diabetic Angiopathies - physiopathology</subject><subject>Diabetic Nephropathies - blood</subject><subject>Diabetic Nephropathies - ethnology</subject><subject>Diabetic Nephropathies - physiopathology</subject><subject>Female</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Proportional Hazards Models</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Serum Albumin - metabolism</subject><issn>1432-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1Lw0AYhBdBbK3-AC-yx3qIvrubzSbeSv2oWBCk97Afb3Q1X80mlfx7A9bLDAzPzGEIuWJwywDUXQBgXEaTRFwqHqkTMmex4BHEPJ2R8xC-AEDIODkjM85lClnG5mS_Maslszf0oDuvjS99P1JdO9p_InV4wLJpK6x72hS08rZrdGmGytfDRFNf035skXLqpi72GO7pLgzfg9H0Vf9oTx-OOX3HDx_6bqT8gpwWugx4efQF2T097tabaPv2_LJebaNWJixyJgGrsqzgDLQFqSxXWZwy4QqGqGIhrbMFKGZSo3QmBToldKKUAcxSg2JBln-zbdfsBwx9XvlgsSx1jc0QcgY8no5jaTqh10d0MBW6vO18pbsx_39J_ALUAmeg</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>Sugawara, A</creator><creator>Kawai, K</creator><creator>Motohashi, S</creator><creator>Saito, K</creator><creator>Kodama, S</creator><creator>Yachi, Y</creator><creator>Hirasawa, R</creator><creator>Shimano, H</creator><creator>Yamazaki, K</creator><creator>Sone, H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201208</creationdate><title>HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2</title><author>Sugawara, A ; Kawai, K ; Motohashi, S ; Saito, K ; Kodama, S ; Yachi, Y ; Hirasawa, R ; Shimano, H ; Yamazaki, K ; Sone, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p561-db60c799f210ac057c2794813df1ee7435cdcf071b8b7a953ed73a677b0e98be3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Albuminuria - urine</topic><topic>Asian Continental Ancestry Group</topic><topic>Blood Glucose - metabolism</topic><topic>Creatinine - urine</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - ethnology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetic Angiopathies - blood</topic><topic>Diabetic Angiopathies - ethnology</topic><topic>Diabetic Angiopathies - physiopathology</topic><topic>Diabetic Nephropathies - blood</topic><topic>Diabetic Nephropathies - ethnology</topic><topic>Diabetic Nephropathies - physiopathology</topic><topic>Female</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Proportional Hazards Models</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Serum Albumin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugawara, A</creatorcontrib><creatorcontrib>Kawai, K</creatorcontrib><creatorcontrib>Motohashi, S</creatorcontrib><creatorcontrib>Saito, K</creatorcontrib><creatorcontrib>Kodama, S</creatorcontrib><creatorcontrib>Yachi, Y</creatorcontrib><creatorcontrib>Hirasawa, R</creatorcontrib><creatorcontrib>Shimano, H</creatorcontrib><creatorcontrib>Yamazaki, K</creatorcontrib><creatorcontrib>Sone, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugawara, A</au><au>Kawai, K</au><au>Motohashi, S</au><au>Saito, K</au><au>Kodama, S</au><au>Yachi, Y</au><au>Hirasawa, R</au><au>Shimano, H</au><au>Yamazaki, K</au><au>Sone, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2</atitle><jtitle>Diabetologia</jtitle><addtitle>Diabetologia</addtitle><date>2012-08</date><risdate>2012</risdate><volume>55</volume><issue>8</issue><spage>2128</spage><epage>2131</epage><pages>2128-2131</pages><eissn>1432-0428</eissn><abstract>The aim of this study was to examine the association between HbA(1c) variability and the development of microalbuminuria as defined by an albumin/creatinine ratio ≥ 3.4 mg/mmol (≥ 30 mg/g) in at least two of three consecutive urine samples in Japanese patients with type 2 diabetes. HbA(1c) level was measured in 812 serially registered normoalbuminuric adults aged 21-79 years with type 2 diabetes. After registration, a 1-year period to establish baseline values for mean HbA(1c) and HbA(1c) variability (measured as the intrapersonal SD of serially collected HbA(1c)) was decided upon. The association between HbA(1c) variability and the development of microalbuminuria was determined by Cox regression analysis after adjustment for other risk factors for microalbuminuria. Microalbuminuria occurred in 193 patients during the observation period of (mean ± SD) 4.3 ± 2.7 years. Even after adjustment for mean HbA(1c), HbA(1c) variability was a significant predictor of microalbuminuria independently of the mean HbA(1c); the HR for every 1% (95% CI) increase in mean HbA(1c) was 1.22 (1.06, 1.40) (p = 0.005), and that for HbA(1c) variability was 1.35 (1.05, 1.72) (p = 0.019). The effects of these two variables were quite similar when 1 SD was used; the HR for every 1 SD increase (95% CI) in HbA(1c) was 1.23 (1.07, 1.43) (p = 0.005), and that for HbA(1c) variability was 1.20 (1.03, 1.39) (p = 0.019). HbA(1c) variability affects the development of microalbuminuria independently of mean HbA(1c) in type 2 diabetes. Further studies should be performed to evaluate the influence of HbA(1c) variability on other complications and in individuals of other ethnicities with type 2 diabetes.</abstract><cop>Germany</cop><pmid>22580991</pmid><doi>10.1007/s00125-012-2572-7</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1432-0428
ispartof Diabetologia, 2012-08, Vol.55 (8), p.2128-2131
issn 1432-0428
language eng
recordid cdi_proquest_miscellaneous_1024100188
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Albuminuria - urine
Asian Continental Ancestry Group
Blood Glucose - metabolism
Creatinine - urine
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - ethnology
Diabetes Mellitus, Type 2 - physiopathology
Diabetic Angiopathies - blood
Diabetic Angiopathies - ethnology
Diabetic Angiopathies - physiopathology
Diabetic Nephropathies - blood
Diabetic Nephropathies - ethnology
Diabetic Nephropathies - physiopathology
Female
Glycated Hemoglobin A - metabolism
Humans
Male
Middle Aged
Predictive Value of Tests
Proportional Hazards Models
Registries
Risk Factors
Serum Albumin - metabolism
title HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A51%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HbA(1c)%20variability%20and%20the%20development%20of%20microalbuminuria%20in%20type%202%20diabetes:%20Tsukuba%20Kawai%20Diabetes%20Registry%202&rft.jtitle=Diabetologia&rft.au=Sugawara,%20A&rft.date=2012-08&rft.volume=55&rft.issue=8&rft.spage=2128&rft.epage=2131&rft.pages=2128-2131&rft.eissn=1432-0428&rft_id=info:doi/10.1007/s00125-012-2572-7&rft_dat=%3Cproquest_pubme%3E1024100188%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024100188&rft_id=info:pmid/22580991&rfr_iscdi=true